Showing results (61-70 of 122) with videos related to
Sort By:
Pageof 13
Research Square|April 17, 2023
Leukemia relapse via genetic immune escape after allogeneic hematopoietic cell transplantationSimona Pagliuca, Carmelo Gurnari, Colin Hercus, et al.Nature Communications|May 31, 2023
Leukemia relapse via genetic immune escape after allogeneic hematopoietic cell transplantationSimona Pagliuca, Carmelo Gurnari, Colin Hercus, et al.Blood Advances|September 17, 2021
Initial therapy for chronic graft-versus-host disease: analysis of practice variation and failure-free survivalJoseph Pidala, Lynn Onstad, Paul J Martin, et al.Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|June 8, 2022
Toxicity analysis of busulfan pharmacokinetic therapeutic dose monitoringKelly J Gaffney, Theresa A Urban, Mariana Lucena, et al.British Journal of Haematology|January 21, 2020
Large granular lymphocytic leukaemia after solid organ and haematopoietic stem cell transplantationHassan Awada, Reda Z Mahfouz, Jibran Durrani, et al.Blood Advances|June 23, 2023
Tacrolimus/methotrexate vs tacrolimus/reduced-dose methotrexate/mycophenolate for graft-versus-host disease preventionBetty K Hamilton, Lisa A Rybicki, Hong Li, et al.Transplantation and Cellular Therapy|May 9, 2021
Systematic Reviews in Hematopoietic Cell Transplantation and Cellular Therapy: Considerations and Guidance from the American Society for Transplantation and Cellular Therapy, European Society for Blood and Marrow Transplantation, and Center for International Blood and Marrow Transplant Research Late Effects and Quality of Life Working CommitteeAkshay Sharma, Sherif M Badawy, Elizabeth M Suelzer, et al.Transplantation and Cellular Therapy|May 19, 2026
Clinical Management of Acute Graft-Versus-Host Disease: An Evidence-Based Review from the ASTCT Committee on Practice GuidelinesZachariah DeFilipp, Amin Alousi, John E Levine, et al.Blood Advances|October 4, 2024
A phase 2 multicenter trial of ruxolitinib to treat bronchiolitis obliterans syndrome after allogeneic HCTZachariah DeFilipp, Haesook T Kim, Guang-Shing Cheng, et al.Clinical Lymphoma, Myeloma & Leukemia|December 7, 2017
Efficacy of Standard Dose R-CHOP Alternating With R-HDAC Followed by Autologous Hematopoietic Cell Transplantation as Initial Therapy of Mantle Cell Lymphoma, a Single-Institution ExperienceYazeed Sawalha, Brian T Hill, Lisa A Rybicki, et al.Pageof 13